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Coronavirus disease 2019 (COVID-19) is a novel infectious disease that spreads rapidly around the world and 
endangers global public health. Because of the lack of specificity of previously identified CT images, such as 
peripheral and subpleural ground glass opacities, early diagnosis is still a big challenge for radiologists. How to 
improve the accuracy of diagnosis and make diagnosis as early as possible is a problem concerned by the medical 
field. This article reports two important CT manifestations in COVID-19 patients, and investigates the 
pathogenesis and clinical significance of them. Single or multiple CT scans in COVID-19 patients confirmed at 
our hospital were retrospectively analyzed. The presence of vascular enlargement sign and bronchiolectasis sign 
on CT images were evaluated with the help of sophisticated post-processing techniques. A total of 14 patients (6 
men and 8 women; mean ± standard deviation age: 41.51 ± 20.98 years) with 34 CT series were included. Vascular 
enlargement sign at a distribution of interior or the edge of pulmonary lesions was observed in all CT series 
(34/34, 100%). Bronchiolectasis sign was observed in 30 CT series (88%), with 4 series (4/7, 57.1%) in early stage, 
16 series (16/16, 100%) in progressive stage, 5 series (5/5, 100%) in severe stage and 9 series (9/9, 100%) in 
absorption stage. The occurrence of bronchiolectasis sign in COVID-19 patients was significantly different 
between early stage and non-early stage (P=0.005). This study suggests that the vascular enlargement sign and 
bronchiolectasis sign are two important CT features in COVID-19 patients and may be of great significance in 
early diagnosis and guiding treatment decisions. 
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Introduction 
In December, 2019, a series of coronavirus disease 2019 
(COVID-19) cases emerged. Since then, the disease has 
spread rapidly around the world, and was declared as a global 
health emergency of world concern by World Health 
Organization (WHO) on February 11, 2020[1-4]. Common 
symptoms of COVID-19 include fever, dry cough, and 
fatigue[5,6]. As of early June, 2020, accumulatively six million 
cases with COVID-19 have been confirmed globally, of whom 
370,000 died[7]. According to the Diagnosis and Treatment 
Plan for New Coronavirus Infected Pneumonia (Sixth Edition), 
radiologic findings, especially computed tomography (CT) 
manifestations, are of great significance in diagnosis and 
guiding therapeutic strategy[8].  
Previous studies indicated that unilateral and bilateral 
peripheral lung distributions of ground-glass opacity (GGO) is 
a typical imaging manifestation of early-stage COVID-19, but 
some radiologists believe that other types of pneumonitis may 
also have this feature[9,10]. With the accumulation of cases, a 
wider spectrum of radiologic findings has been reported, 
including crazy paving pattern, halo sign, reversed halo sign, 
cavity, etc[11-14]. In particular, we noticed the occurrence of 
vascular enlargement and bronchiolectasis in many COVID-
19 cases, may be helpful for early diagnosis and guiding 
treatment. However, the two signs have not been reviewed 
comprehensively with regard to the pathology and 
pathophysiology.  
Therefore, in this retrospective study, we reported in 
detail the two important CT manifestations in COVID-19 
patients, vascular enlargement sign and bronchiolectasis sign, 
and investigated their pathogenesis and clinical significance in 
combination with the latest autopsy pathology reports. CT 
post-processing was also performed to reconstruct images for 
better visualization of these signs, thereby increasing correct 
diagnoses.  
Patient and Method 
This retrospective study was approved by local Ethics of 
Committee. Patient inclusion criteria were as follows: (a) 
Patients had a positive result of real-time reverse transcription 
polymerase chain reaction (RT-PCR) test for severe acute 
respiratory syndrome coronavirus 2 (SARS-CoV-2); (b) 
Patients underwent a single or multiple thin-section CT 
examinations at our hospital; (c) CT scans showed pulmonary 
abnormalities. From January 23, 2020 to February 15, 2020, 
15 patients were consecutively employed. One patient was 
excluded for only having a single CT scan with normal result. 
The remaining 14 patients were finally included.  
CT Protocol and Image Reconstruction 
Unenhanced chest CT examination was performed in a 64-
row, 128-section spiral scanner (Siemens Somatom 
Perspective, Germany) with the following parameters: tube 
voltage, 80/100kV; tube current, 50 mAs; CARE Dose, on; 
rotation time, 0.6 s; pitch, 1.45; section thickness, 5 mm; 
section interval, 5 mm; collimator, 64 × 0.6 mm; and matrix, 
512 × 512. Images were reconstructed using the iterative 
reconstruction technique with a thickness of 1 mm and an 
interval of 0.7 mm. All images were transferred to Siemens 
workstation (syngo.via, version 4.1) and post-processed by 
using the PULMO 3D software (VB20, Siemens Healthineers, 
Forchheim, Germany). In the reconstructed two-dimensional 
images, pulmonary parenchyma and vessels were 
differentiated by CT values and highlighted in different 
pseudo-colors. 
Image Interpretation  
All CT images were independently reviewed and analyzed 
by two senior radiologists, each with more than 10 years of 
experience in thoracic imaging diagnosis. A third radiologist 
(more than 20 years of experience) would be consulted and 
make the final decision when disagreement occurred. The 
following CT indicators were evaluated: (a) vascular 
enlargement sign, defined as the presence of dilated blood 
vessels in or around pulmonary lesions; (b) bronchiolectasis 
sign, defined as the dilated bronchioles in or around 
pulmonary lesions; and (c) disease severity based on 
radiologic findings: early stage, progressive stage, severe 
stage and absorptive stage [10]. 
Statistical Analysis 
All data were analyzed with Pearson’s chi-squared test 
(categorical variables) or Fisher’s exact test using SPSS 
software (version 24.0, SPSS Inc, Chicago, IL, USA). Two-
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Figure 1. The vascular enlargement sign. (A, B, C) Axial thin-section unenhanced CT shows vascular enlargement (white 
arrows) in or around the ground-glass opacities.(D) PULMO-3D reconstructed images of C with highlight of enlarged vessels. 
 
Figure 2. The vascular enlargement sign and bronchiolectasis sign. (A, B) Axial thin-section CT scans show simultaneous 
vessels and bronchioles dilatation in the ground glass opacities (red frames). The diameter of the dilated distal bronchioles is 
equal to or less than that of the adjacent dilated vessels. 
 
 
A total of 34 CT scans (mean interval: 3.78 days, range: 2-
7 days) from 14 patients (6 males and 8 females; 41.51 ± 20.98 
years) were assessed (Table 1). 
Clinical and Laboratory Findings 
Of the 14 patients, two had hypertension, one had chronic 
bronchitis, one had myocardial ischemia, and the other 10 
cases had no special medical history. Nine patients (64%) had 
a history of traveling or living in Wuhan, and five patients 
(36%) had close contacts with people from Hubei Province, 
China. The most common clinical symptoms were fever 
(11/14, 79%) and cough (11/14, 79%), and three patients had 
normal body temperature. Other symptoms included fatigue, 
runny nose, chest tightness, palpitation, and shortness of 
breath. 
The blood counts showed normal white blood cell count  
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Figure 3. A 34-year-old female patient with COVID-19 in early stage. (A) Axial thin-section unenhanced CT scan shows 
a single ground-glass nodule. (B, C, D) PULMO-3D reconstructed images show vascular enlargement more clearly (white 
arrows). 
 
(10/14, 71%) and low lymphocyte levels (8/14, 57%) in most 
patients. C-reactive protein was increased in 10 cases (71%), 
and sedimentation rate was elevated in 8 cases (57%). 
Elevations of creatinine, lactate dehydrogenase, creatine 
kinase and D-dimer were shown in some patients. Twelve 
patients (86%) were tested positive in the first RT-PCR assay 
for detecting COVID-19 using nasopharyngeal swab. One 
patient was tested negative in the first two pharynx swab tests 
and positive in the third alveolar lavage fluid test. Two patients 
(14%) had positive results in anal swab RT-PCR tests. Other 
samples, such as milk and urine, were not detected with 
COVID-19 nucleic acid. 
CT Imaging Findings 
Presence and distribution of ground glass opacities 
Of the 14 initial chest CT scans, one (7%) presented with a 
single ground glass nodule with a diameter of 10 mm, one (7%) 
presented with a rounded mass shadow, and the other 12 cases 
(86%) presented with multiple ground glass opacities in 
bilateral lungs. All lesions were distributed mainly in the outer 
pulmonary field or subpleura. Pulmonary lobe involvement 
included one-lobe involvement in one case (7%), three-lobe 
involvement in 3 cases (21%), four-lobe involvement in 2 
cases (14%), and five-lobe involvement in 8 cases (58%). A 
total of 58 lung lobes were involved, including 12 cases (21%) 
in the upper lobe of the left lung, 12 cases (21%) in the lower 
lobe of the left lung, 11 cases (19%) in the upper lobe of the 
right lung, 9 cases (15%) in the middle lobe of the right lung, 
and 14 cases (24%) in the lower lobe of the right lung.  
With regard to illness assessment, the initial CT scans 
showed early stage of disease in 5 patients (36%), severe stage 
in 2 (14%), and progressive stage in 7 (50%). During 
hospitalization, 12 patients received two or more CT 
examinations to monitor disease progression. Four patients 
(28%) became worse in a short time, presenting with enlarged 
scope and volume of lesions in the bilateral lungs, and one of 
them had a 10-year history of chronic bronchitis. One patient 
(7%), aged 59 years, showed disease progression again after 
the improvement of absorption. Two severe cases (14%), who 
had hypertension and myocardial ischemia, respectively, 
improved slowly, presenting with multiple large flakes of 
ground-glass shadows and consolidation foci in the lungs. One 
patient did not show disease progression (7%), and 4 patients 
showed gradual absorption of lesions (28%).  
Other abnormalities were also seen in some patients, 
including 1 patient (7%) with two calcification nodules in the 
upper lobe of the right lung, 1 patient (7%) with a lung mass 
in the lower lobe of the right lung, and 3 patients (21%) with 
chronic fibrosis in the lungs. Meanwhile, mild bilateral pleural 
effusion was found in one case (7%), and no enlargement of 
mediastinal or hilar lymph nodes was found. 
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Figure 4. A 33-year-old male patient with COVID-19 in early stage. (A) Axial thin-section unenhanced CT shows a 
rounded ground-glass opacity with vascular enlargement and bronchiolectasis sign (vascular enlargement in red arrows 
and bronchiolectasis in yellow arrow) and patchy high density area (white arrow). (B,C) PULMO-3D reconstructed 
images clearly show dilated bronchioles (yellow arrows)and suspected intra-focal hemorrhage (white arrow). (D) 
Maximum intensity projection (MIP) reconstruction. (E,F) Coronal and sagittal PULMO-3D reconstruction images 
clearly show dilated bronchioles (yellow arrow) and suspected intra-focal hemorrhage (white arrow). 
 
The vascular enlargement sign and bronchiolectasis sign 
Vascular enlargement sign was observed in all CT series 
(34/34, 100%), which was mainly distributed at the interior or 
the edge of ground-glass shadows and consolidated areas A 
representative image is shown in Figure 1. In conventional 
thin-slice CT images, vascular enlargement sign in small 
lesions may be not recognized without pseudo-color 
reconstruction (Figure 3). Moreover, bronchiolectasis sign 
(Figures 2 and 4) was observed in most series (30/34, 88%), 
including 4 series (4/7, 57.1%) at the early stage, 16 series 
(16/16, 100%) at the progressive stage, 5 series (5/5, 100%) at 
the severe stage and 9 series (9/9, 100%) at the absorption 
stage. The incidence of bronchiolectasis sign in COVID-19 
patients differed significantly between early-stage and other 
stages (p =0.005). 
Discussion 
The number of COVID-19 infections is still increasing 
since the outbreak, and has become a great threat to global 
public health [15-17]. Consistent with the previous literature, 
most of our cases (12 of 14, 86%) presented with multiple 
GGO in the peripheral and subpleural zone of unilateral or 
bilateral lungs. However, two cases in this report presented 
with a single ground glass nodule (Figure 3) and a rounded 
mass shadow (Figure 4), which are difficult to be 
differentiated from other lesions such as pure ground-glass 
nodule, other types of pneumonia, and inflammatory 
pseudotumor. At the early stage of disease, it may be a big 
challenge for radiologists to identify these atypical CT 
findings and make correct diagnosis. Yet, in our study, we 
found two important CT imaging features, vascular 
enlargement sign and bronchiolectasis sign, which may be 
helpful for early diagnosis and differential diagnosis of 
COVID-19 pneumonia. Moreover, the reconstruction 
techniques of PULMO 3D software are helpful to identify 
these two signs in pulmonary lesions. 
Initially, pathologists performed needle sampling from a 
COVID-19 cadaver, and the local histopathological changes 
of COVID-19 were very similar to those of SARS and Middle 
East respiratory syndrome (MERS). The bilateral diffuse 
alveolar damage with fibromyxoid exudates, transparent 
membrane formation and pulmonary edema, is indicative of 
acute respiratory distress syndrome (ARDS) [18-20]. On 
February 16, 2020, Liu et al. performed a systematic autopsy 
on a COVID-19 cadaver. Gross anatomy showed pulmonary 
venous congestion with focal hemorrhage. Some lung lobules 
expanded and turned white, mixed with dark red areas of 
congestion and hemorrhage, mainly distributed in the outer 
field of the lung. After incision, a large amount of offwhite 
mucus flew out, the trachea cavity was filled with white foam 
mucus, and the gelatinous mucus was attached to the bronchial 
lumen [21].  
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The complete pathological findings were published in the 
Diagnosis and Treatment Plan for New Coronavirus Infected 
Pneumonia (seventh edition) on March 4, 2020[22]. These 
include presence of serous fluid, fibrin exudate and transparent 
membrane in alveoli; significant proliferation of type II 
alveolar epithelial cells, with virus inclusion bodies thereof; 
alveolar septal vessels showing hyperemia, edema, 
inflammatory cell infiltration, and transparent thrombus 
formation; occurrence of focal hemorrhage, necrosis, and 
hemorrhagic infarction in the lung tissues; partial fall off of 
the bronchial mucosa, with formation of mucus and mucus 
embolus in cavity; presence of coronavirus particles in the 
cytoplasm of bronchial mucosal epithelial and type II alveolar 
epithelial cells under electron microscopy; and COVID-19 
antigen-positive alveolar epithelium cells and macrophages as 
evidenced by immunohistochemistry. These pathological 
findings can explain the CT imaging alterations of COVID-19.  
The inflammation starts from bronchi and bronchioles, and 
develops along the interstitium of the lungs. The alveolar septa 
are widened, with no exudation or little exudation in the 
alveolar cavity. At this point, chest CT may reveal no special 
changes, and the patient may be asymptomatic or only have 
mild symptoms. 
As the disease progresses, bronchi, bronchioles and 
surrounding capillaries were further burdened with congestion 
and edema, due to the infiltration of inflammatory cells. The 
bronchial tube wall and alveolar wall undergo denaturation, 
necrosis and exudation, and severe inflammatory exudation 
occurs in the alveolar cavity. Thus, the peripheral GGO 
appears on CT imaging, which indicates the early stage of 
COVID-19. This completely corresponds to the offwhite 
alveolar lesions seen in the gross anatomy, suggesting that 
COVID-19 mainly causes an inflammatory response 
characterized by damage to the distal small airway and 
alveoli[21]. 
At the early or progressive stage, dilated blood vessels 
appear in or around the GGOs, which is the so-called vascular 
enlargement sign. Zhao et al. proposed that the vascular 
enlargement may be caused by acute inflammatory responses, 
and suggested that its feature of being distributed in the 
peripheral lung could be used to distinguish COVID-19 from 
lung adenomas which are characterized by thickened blood 
vessels [23]. In our study, however, we found that these dilated 
vessels originate from the veins, which is consistent with the 
pulmonary congestion seen from gross anatomy. We speculate 
that there may be transparent thrombosis in the venule lumen, 
causing local obstruction and then dilation of the distal vessels. 
Furthermore, there were patch-like high-density shadows in 
some lesions (Figure 4), consistent with the vascular density, 
especially in the reconstructed images of PULMO 3D. We 
considered the high-density shadows to be a focal 
hemorrhagic lesion. The thickening and dilatation of small 
vessels in the lesion area may cause damage to the vascular 
endothelium, resulting in increased permeability, even rupture 
and bleeding of the vessel wall. In addition, the CT post-
processing techniques revealed a vascular dilatation sign 
within a 10-mm small ground-glass nodule in this series of 
cases (Figure 3), suggesting that this sign could be used to 
guide early diagnosis of COVID-19.  
In this study, we found presence of dilated bronchioles in or 
around pulmonary lesions, namely, bronchiolectasis sign. The 
diameter of the dilated distal bronchioles was similar or 
smaller than that of the adjacent dilated vessels. This sign was 
referred to as air bronchogram and tractive bronchiectasis in 
previous studies[24-26]. However, as they are more commonly 
seen in pulmonary consolidation and late period of 
inflammation, respectively, bronchiolectasis occurs more 
specifically at the early or progressive stage of COVID-19. 
From the time window of the three signs, the bronchiolectasis 
sign of COVID-19 has an earliest occurrence. Since gross 
anatomy revealed a large amount of mucus in the lung tissue, 
trachea and bronchial lumen after incision, we speculated that 
the bronchiolectasis sign may be associated with mucus 
attachment or partial lumen obstruction. This explains why 
most patients present with dry cough and no sputum. 
Therefore, the appearance of bronchiolectasis sign may 
indicate the formation of mucus embolus in the bronchial 
lumen. Clinicians should pay more attention to this sign and 
take further measures to dilute sputum and promote sputum 
elimination (e.g., sputum aspiration, sputum medication, etc.), 
thus preventing worsening of the disease. 
In severe cases, due to extensive denaturation and necrosis 
of bronchi and alveolar wall, and the formation of transparent 
membrane, pulmonary foci are enlarged substantially, lungs 
become consolidated, even white lung signs appear. In this 
period, due to the high density of consolidated lung tissues, 
the vascular enlargement and bronchiolectasis signs cannot be 
clearly displayed on conventional thin-slice CT images, but 
post-processing techniques can facilitate better visualization 
of these signs in patients. Due to the large amount of jelly-like 
phlegm obstruction in peripheral lung tissue and poor drainage 
of pulmonary secretions, the ventilation function of 
respiratory pulmonary lobule is seriously impaired, causing 
significant decrease of oxygenation index of the patients. 
During this period, hypoxia may hardly be reversed even if 
patients are given adequate oxygen therapy. Therefore, early 
identification of bronchiolectasis is of great significance in 
guiding clinical treatment.  
Limitations 
There are some limitations in this study. First, the number 
of patients was relatively small, and some patients did not 
undergo follow-up CT examination. Seven patients only had 
one follow-up CT in the study window. Second, the 
pathophysiological mechanism of COVID-19 is still under 
investigation. Our analysis of the vascular enlargement and 
Inflammation and Cell Signaling 2020; 7: e1168. doi: 10.14800/ics.1168; ©  2020 by Lei Tang, et al. 
http://www.smartscitech.com/index.php/ics 
 
Page 7 of 8 
 
bronchiolectasis signs is based on the pathological findings of 
COVID-19 autopsy and the knowledge on pathogenesis of 
ARDS, so further clinicopathological studies are needed for 
verification. Third, the two signs have been seen in some cases 
of SARS and MERS[23-25], thus may be a specific sign for 
coronavirus pneumonia (especially COVID-19). Large-
sample comparative studies are needed for clarification. 
Conclusion 
Vascular enlargement and bronchiolectasis are two 
important CT signs of COVID-19 pneumonia, which begin to 
appear at the early or progressive stage of the disease. 
Recognition and familiarity with these signs could help 
radiologists make diagnosis as early as possible, which is of 
great significance for controlling the spread of the disease. The 
appearance of bronchiolectasis sign indicates the formation of 
mucus embolus in the bronchial lumen, which may have 
certain guiding significance for clinical treatment. 
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